Search Results - "Jeenarain, Nitesha"

Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial by Browne, Erica N., Brown, Elizabeth R., Palanee-Phillips, Thesla, Reddy, Krishnaveni, Naidoo, Logashvari, Jeenarain, Nitesha, Nair, Gonasagrie, Husnik, Marla J., Singh, Devika, Scheckter, Rachel, Soto-Torres, Lydia, Baeten, Jared M., van der Straten, Ariane

“…Persistent use of HIV prevention methods can be a challenge, particularly for some younger women. The long-acting, discreet, woman-centric dapivirine vaginal…”
Get full text

Brief Report: Dapivirine Ring HIV-1 Prevention Effectiveness for Women Engaged in Vaginal and Anal Intercourse: Insights From Mathematical Modeling by Peebles, Kathryn, Brown, Elizabeth R., Hendrix, Craig W., Palanee-Phillips, Thesla, van der Straten, Ariane, Harkoo, Ishana, Reddy, Krishnaveni, Mirembe, Brenda G., Jeenarain, Nitesha, Hillier, Sharon L., Baeten, Jared M., Barnabas, Ruanne V.

“…The dapivirine vaginal ring reduces the risk of HIV-1 acquisition in acts of vaginal intercourse (VI), and although it does not offer HIV-1 protection in acts…”
Get full text

Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial by Mayo, Ashley J., Browne, Erica N., Montgomery, Elizabeth T., Torjesen, Kristine, Palanee-Phillips, Thesla, Jeenarain, Nitesha, Seyama, Linly, Woeber, Kubashni, Harkoo, Ishana, Reddy, Krishnaveni, Tembo, Tchangani, Mutero, Prisca, Tauya, Thelma, Chitukuta, Miria, Gati Mirembe, Brenda, Soto-Torres, Lydia, Brown, Elizabeth R., Baeten, Jared M., van der Straten, Ariane

“…We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the…”
Get full text

Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial by Goga, Ameena, Ramraj, Trisha, Naidoo, Logashvari, Daniels, Brodie, Matlou, Masefetsane, Chetty, Terusha, Dassaye, Reshmi, Ngandu, Nobubelo K, Galli, Laura, Reddy, Tarylee, Seocharan, Ishen, Ndlangamandla, Qondeni, September, Qholokazi, Ngcobo, Nokwanda, Reddy, Mayuri, Cafun-Naidoo, Tamon, Woeber, Kubashni, Jeenarain, Nitesha, Imamdin, Rabia, Maharajh, Keshnee, Ramjeth, Ashmintha, Bhengu, Thobile, Clarence, Emma, Van de Perre, Philippe, Tylleskär, Thorkild, Nagot, Nicolas, Moles, Jean-Pierre, Moore, Penny L, Mkhize, Nonhlanhla N, Gama, Lucio, Dispinseri, Stefania, Biswas, Priscilla, Scarlatti, Gabriella

“…The ambitious goal to eliminate new pediatric HIV infections by 2030 requires accelerated prevention strategies in high-risk settings such as South Africa. One…”
Get full text

Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention by Husnik, Marla J., Brown, Elizabeth R., Dadabhai, Sufia S., Gaffoor, Zakir, Jeenarain, Nitesha, Kiweewa, Flavia Matovu, Livant, Edward, Mansoor, Leila E., Mirembe, Brenda Gati, Palanee-Phillips, Thesla, Singh, Devika, Siva, Samantha, Soto-Torres, Lydia, van der Straten, Ariane, Baeten, Jared M.

“…Understanding characteristics associated with adherence to pre-exposure prophylaxis (PrEP) methods for HIV-1 prevention may assist with optimizing…”
Get full text

Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study by Garcia, Morgan, Luecke, Ellen, Mayo, Ashley J, Scheckter, Rachel, Ndase, Patrick, Kiweewa, Flavia Matovu, Kemigisha, Doreen, Musara, Petina, Mansoor, Leila E, Singh, Nishanta, Woeber, Kubashni, Morar, Neetha S, Jeenarain, Nitesha, Gaffoor, Zakir, Gondwe, Daniel K, Makala, Yvonne, Fleurs, Llewellyn, Reddy, Krishnaveni, Palanee-Phillips, Thesla, Baeten, Jared M, van der Straten, Ariane, Soto-Torres, Lydia, Torjesen, Kristine

“…Low adherence to investigational products can negatively impact study outcomes, limiting the ability to demonstrate efficacy. To continue advancing potential…”
Get full text

Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial by Pleasants, E., Tauya, T., Reddy, K., Mirembe, B. G., Woeber, K., Palanee-Phillips, T., Zimba, C., Atujuna, M., Montgomery, E. T.

“…Gender roles and imbalances in sexual power contribute to the heightened HIV-1 risk faced by women in Sub-Saharan Africa. This has led prevention research to…”
Get full text

Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe by Duby, Zoe, Katz, Ariana W. K., Browne, Erica N., Mutero, Prisca, Etima, Juliane, Zimba, Chifundo Colleta, Woeber, Kubashni, Atujuna, Millicent, Reddy, Krishnaveni, van der Straten, Ariane

“…We assessed the interference between vaginal ring use and menses among women who participated in the qualitative component of the MTN-020/ASPIRE vaginal ring…”
Get full text

The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence by Stoner, Marie C. D., Brown, Elizabeth R., Palanee-Phillips, Thesla, Mansoor, Leila E., Tembo, Tchangani, Nair, Gonasagrie, Akello, Carolyne, Seyama, Linly, Jeenarain, Nitesha, Naidoo, Logashvari, Mgodi, Nyaradzo, Hunidzarira, Portia, Chitukuta, Miria, van der Straten, Ariane

“…We analyzed data from 1428 users of the dapivirine vaginal ring, who participated in the MTN-020/ASPIRE phase III trial and subsequent open-label extension…”
Get full text

Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention by Palanee-Phillips, Thesla, Schwartz, Katie, Brown, Elizabeth R, Govender, Vaneshree, Mgodi, Nyaradzo, Kiweewa, Flavia Matovu, Nair, Gonasagrie, Mhlanga, Felix, Siva, Samantha, Bekker, Linda-Gail, Jeenarain, Nitesha, Gaffoor, Zakir, Martinson, Francis, Makanani, Bonus, Naidoo, Sarita, Pather, Arendevi, Phillip, Jessica, Husnik, Marla J, van der Straten, Ariane, Soto-Torres, Lydia, Baeten, Jared

“…Women in sub-Saharan Africa are a priority population for evaluation of new biomedical HIV-1 prevention strategies. Antiretroviral pre-exposure prophylaxis is…”
Get full text

HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial by Riddler, Sharon A, Husnik, Marla, Ramjee, Gita, Premrajh, Anamika, Tutshana, Bomkazi Onini, Pather, Arendevi, Siva, Samantha, Jeenarain, Nitesha, Nair, Gonasagrie, Selepe, Pearl, Kabwigu, Samuel, Palanee-Phillips, Thesla, Panchia, Ravindre, Mhlanga, Felix, Levy, Lisa, Livant, Edward, Patterson, Karen, Elharrar, Vanessa, Balkus, Jennifer

“…Little is known regarding HIV disease outcomes among individuals who become infected with HIV while receiving antiretroviral medications for prevention. We…”
Get full text

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women by Baeten, Jared M, Palanee-Phillips, Thesla, Brown, Elizabeth R, Schwartz, Katie, Soto-Torres, Lydia E, Govender, Vaneshree, Mgodi, Nyaradzo M, Matovu Kiweewa, Flavia, Nair, Gonasagrie, Mhlanga, Felix, Siva, Samantha, Bekker, Linda-Gail, Jeenarain, Nitesha, Gaffoor, Zakir, Martinson, Francis, Makanani, Bonus, Pather, Arendevi, Naidoo, Logashvari, Husnik, Marla, Richardson, Barbra A, Parikh, Urvi M, Mellors, John W, Marzinke, Mark A, Hendrix, Craig W, van der Straten, Ariane, Ramjee, Gita, Chirenje, Zvavahera M, Nakabiito, Clemensia, Taha, Taha E, Jones, Judith, Mayo, Ashley, Scheckter, Rachel, Berthiaume, Jennifer, Livant, Edward, Jacobson, Cindy, Ndase, Patrick, White, Rhonda, Patterson, Karen, Germuga, Donna, Galaska, Beth, Bunge, Katherine, Singh, Devika, Szydlo, Daniel W, Montgomery, Elizabeth T, Mensch, Barbara S, Torjesen, Kristine, Grossman, Cynthia I, Chakhtoura, Nahida, Nel, Annalene, Rosenberg, Zeda, McGowan, Ian, Hillier, Sharon

“…Development of HIV-1 prevention methods is a global priority. In this randomized, controlled trial in sub-Saharan Africa, a vaginal ring containing the…”
Get full text

Dapivirine ring HIV-1 prevention effectiveness for women engaged in vaginal and anal intercourse: insights from mathematical modeling by Peebles, Kathryn, Brown, Elizabeth R., Hendrix, Craig W., Palanee-Phillips, Thesla, van der Straten, Ariane, Harkoo, Ishana, Reddy, Krishnaveni, Mirembe, Brenda G., Jeenarain, Nitesha, Hillier, Sharon L., Baeten, Jared M., Barnabas, Ruanne V.

Get full text

Elevated Risk of Bacterial Vaginosis among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study by Peebles, Kathryn, Kiweewa, Flavia M, Palanee-Phillips, Thesla, Chappell, Catherine, Singh, Devika, Bunge, Katherine E, Naidoo, Logashvari, Makanani, Bonus, Jeenarain, Nitesha, Reynolds, Doerieyah, Hillier, Sharon L, Brown, Elizabeth R, Baeten, Jared M, Balkus, Jennifer E

“…Limited evidence suggests that the non-hormonal contraceptive copper intrauterine device (Cu-IUD) may increase bacterial vaginosis (BV) risk, possibly due to…”
Get full text

Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial by Browne, Erica N, Brown, Elizabeth R, Palanee-Phillips, Thesla, Reddy, Krishnaveni, Naidoo, Logashvari, Jeenarain, Nitesha, Nair, Gonasagrie, Husnik, Marla J., Singh, Devika, Scheckter, Rachel, Soto-Torres, Lydia, Baeten, Jared M., van der Straten, Ariane

Get full text

Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex by Browne, Erica N., Torjesen, Kristine, Mirembe, Brenda Gati, Palanee-Phillips, Thesla, Jeenarain, Nitesha, Chitukuta, Miria, Stoner, Marie C. D., Mansoor, Leila E., Reddy, Krishnaveni, Tauya, Thelma T., Naidoo, Logashvari, Siva, Samantha, Richardson, Barbra, Dadabhai, Sufia, Seyama, Linly, Soto-Torres, Lydia, van der Straten, Ariane

“…We assessed if acceptability of the dapivirine vaginal ring for HIV prevention differed among the subgroup of women who reported engaging in transactional sex…”
Get full text

Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial by Brown, Elizabeth R, Hendrix, Craig W, Straten, Ariane, Kiweewa, Flavia M, Mgodi, Nyaradzo M, Palanee‐Philips, Thesla, Marzinke, Mark A, Bekker, Linda‐Gail, Soto‐Torres, Lydia, Hillier, Sharon L, Baeten, Jared M, Palanee‐Phillips, Thesla, Schwartz, Katie, Martinson, Francis, Govender, Vaneshree, Siva, Samantha, Gaffoor, Zakir, Naidoo, Logashvari, Pather, Arendevi, Jeenarain, Nitesha

“…Introduction A vaginal ring containing 25 mg of the antiretroviral dapivirine has demonstrated efficacy in reducing women’s risk of sexually acquiring HIV‐1;…”
Get full text

Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring by Stalter, Randy M, Dong, Tracy Q, Hendrix, Craig W, Palanee-Phillips, Thesla, van der Straten, Ariane, Hillier, Sharon L, Kiweewa, Flavia M, Mgodi, Nyaradzo M, Marzinke, Mark A, Bekker, Linda-Gail, Soto-Torres, Lydia, Baeten, Jared M, Brown, Elizabeth R

“…Abstract Background Confounding introduced by individuals’ sexual risk behavior is potentially a significant source of bias in HIV-1 prevention intervention…”
Get full text

Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization by Liu, Gui, Mugo, Nelly R., Brown, Elizabeth R., Mgodi, Nyaradzo M., Chirenje, Zvavahera M., Marrazzo, Jeanne M., Winer, Rachel L., Mansoor, Leila, Palanee-Phillips, Thesla, Siva, Samantha S., Naidoo, Logashvari, Jeenarain, Nitesha, Gaffoor, Zakir, Nair, Gonasagrie L., Selepe, Pearl, Nakabiito, Clemensia, Mkhize, Baningi, Mirembe, Brenda Gati, Taljaard, Marthinette, Panchia, Ravindre, Baeten, Jared M., Balkus, Jennifer E., Hladik, Florian, Celum, Connie L., Barnabas, Ruanne V.

“…Vaccine-preventable human papillomavirus (HPV) infection is common, especially in sub-Saharan Africa where HIV risk is also high. However, unlike other…”
Get full text

Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization by Liu, Gui, Mugo, Nelly R., Brown, Elizabeth R., Mgodi, Nyaradzo M., Chirenje, Zvavahera M., Marrazzo, Jeanne M., Winer, Rachel L., Mansoor, Leila, Palanee-Phillips, Thesla, Siva, Samantha S., Naidoo, Logashvari, Jeenarain, Nitesha, Gaffoor, Zakir, Nair, Gonasagrie L., Selepe, Pearl, Nakabiito, Clemensia, Mkhize, Baningi, Mirembe, Brenda Gati, Taljaard, Marthinette, Panchia, Ravindre, Baeten, Jared M., Balkus, Jennifer E., Hladik, Florian, Celum, Connie L., Barnabas, Ruanne V.

Get full text